Who Paid My Doc
Bethkis
Drug Cystic Fibrosis
NDC 10122-820-56
General payments
$76,904
Research payments
$0
Through program year 2022, $76,904 in general payments and $0 in research payments were reported against Bethkis (Cystic Fibrosis).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | General | $5,661 | 37 |
| 2021 | General | $5,617 | 48 |
| 2020 | General | $8,415 | 290 |
| 2019 | General | $57,210 | 463 |
Breakdown
The top 5 of 24 recipients; each share is of general payments naming this product in 2022.
The top 5 of 9 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.
The top 5 of 9 states; each share is of general payments naming this product in 2022 where a state was reported.
Records
838 generalEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.